Edwards Lifesciences Corporation (EW) vs Regeneron Pharmaceuticals, Inc. (REGN)
REGN leads on 13 of 16 compared metrics.
A side-by-side comparison of Edwards Lifesciences Corporation and Regeneron Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 28, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
EW
Edwards Lifesciences Corporation
$90.78Healthcare
REGN
Regeneron Pharmaceuticals, Inc.
$632.90Healthcare
Total return — EW vs REGN
growth of $100 · last 26yEW +6502.2%REGN +1655.1%EW compounded faster
EW REGN
EW vs REGN: by the numbers
- •REGN is the larger company ($65.20B vs $52.27B market cap).
- •REGN trades at the lower earnings multiple (15.42 vs 48.29 P/E).
- •REGN converts more revenue to profit (29.65% vs 17.34% net margin).
- •REGN grew revenue faster over the past five years (10.16% vs 7.10% CAGR).
- •REGN pays a dividend (0.59% yield) while EW does not currently pay one.
Which is better, EW or REGN?
Metric tally: EW 3 · REGN 13It depends on what you're optimizing for:
ValueREGN(lower P/E)
GrowthREGN(faster 5Y revenue CAGR)
QualityEW(higher ROIC)
Metrics side by side
Valuation
| Metric | EW | REGN |
|---|---|---|
| P/E ratio | 48.29 | 15.42● |
| Forward P/E | 26.89 | 11.69● |
| P/S ratio | 8.36 | 4.57● |
| P/B ratio | 5.10 | 2.17● |
| PEG ratio | 7.03 | 3.38● |
| EV / EBITDA | 26.80 | 16.29● |
| FCF yield | 2.07% | 6.10%● |
Profitability
| Metric | EW | REGN |
|---|---|---|
| Gross margin | 78.01% | 84.55%● |
| Operating margin | 27.62%● | 24.32% |
| Net margin | 17.34% | 29.65%● |
| ROE | 10.58% | 14.08%● |
| ROIC | 11.40%● | 8.51% |
Dividends
| Metric | EW | REGN |
|---|---|---|
| Dividend yield | — | 0.59% |
| Payout ratio | — | 8.73% |
Growth (annualized)
| Metric | EW | REGN |
|---|---|---|
| Revenue CAGR (5Y) | 7.10% | 10.16%● |
| EPS CAGR (5Y) | 6.87%● | 5.70% |
| FCF CAGR (5Y) | 8.74% | 15.42%● |
| Total return CAGR (5Y) | -2.60% | 2.99%● |
Frequently asked
- Which is better, EW or REGN?
- It depends on your goal. value: REGN (lower P/E); growth: REGN (faster 5Y revenue CAGR); quality: EW (higher ROIC). Across all compared metrics, REGN leads 13 to 3.
- Is EW or REGN cheaper?
- On trailing earnings, REGN is cheaper: EW trades at a 48.29 P/E and REGN at 15.42.
- Which has grown faster, EW or REGN?
- Over the past five years, REGN grew revenue faster — EW at a 7.10% CAGR versus REGN at 10.16%.
- Does EW or REGN pay a bigger dividend?
- REGN pays a dividend (0.59% yield) while EW does not currently pay one.
- Is EW or REGN more profitable?
- REGN runs the higher net margin — EW at 17.34% versus REGN at 29.65%.
- Which has been the better investment, EW or REGN?
- Over the past 10-year, EW delivered the higher annualized total return — EW at 10.98% versus REGN at 6.51%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Edwards Lifesciences P/E ratioRegeneron Pharmaceuticals P/E ratioEdwards Lifesciences dividend yieldRegeneron Pharmaceuticals dividend yieldEdwards Lifesciences ROERegeneron Pharmaceuticals ROEEdwards Lifesciences operating marginRegeneron Pharmaceuticals operating marginEdwards Lifesciences revenue growthRegeneron Pharmaceuticals revenue growthEdwards Lifesciences free cash flowRegeneron Pharmaceuticals free cash flow
Edwards Lifesciences & Regeneron Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 28, 2026.